Prediction of Mode of Death in Heart Failure: The Seattle Heart Failure Model

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Circulation

• Publication date

  2007-07-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.106.687103PMID 17620506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Seattle Heart Failure Model: Prediction of Survival in Heart Failure

  2006cited by this paper
• Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2006cited by this paper
• Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice.

  2005cited by this paper
• Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure.

  2004cited by this paper
• Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

  2004cited by this paper
• Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)

  2004cited by this paper
• The adult patient with native coarctation of the aorta: balloon angioplasty or primary stenting?

  2003cited by this paper
• Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.

  2003cited by this paper
• Mode of death in heart failure: findings from the ATLAS trial

  2003cited by this paper
• Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

  2002cited by this paper
• PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION

  2002cited by this paper
• Diuretic resistance predicts mortality in patients with advanced heart failure.

  2002cited by this paper
• Literature alert

  2002cited by this paper
• A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

  2001cited by this paper
• The heart failure epidemic: exactly how big is it?

  2001cited by this paper
• Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

  2000cited by this paper
• The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure.

  1999cited by this paper
• Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery.

  1999cited by this paper
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

  1999cited by this paper
• Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

  1996cited by this paper
• The Clinical Perspective

  1994cited by this paper
• Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

  1992cited by this paper

• The value of CA125 in predicting adverse outcomes in heart failure patients

  2025cites this paper
• A Cardiac Magnetic Resonance–Based Risk Stratification for Life‐Threatening Ventricular Tachyarrhythmias in Heart Failure: The SNE2 Score

  2025cites this paper
• Comprehensive Symptom Assessment of Patients With End-Stage Heart Failure Referred to Palliative Care.

  2025cites this paper
• Can We Make the Next Step in Precision Risk Stratification of Dilated Cardiomyopathy?

  2025cites this paper
• Static Versus Dynamic Risk of Sudden Cardiac Death: Implications for Improvement of Prediction and Prevention

  2025cites this paper
• Safety and Prognostic Implications of Mechanical Circulatory Support‐Assisted Transcatheter Edge‐to‐Edge Repair: The OCEAN‐Mitral Registry

  2025cites this paper
• Prognosis and Risk Stratification in Dilated Cardiomyopathy With LVEF≤35%: Cardiac MRI Insights for Better Outcomes

  2025cites this paper
• Factors associated with 30-day mortality in patients with acute heart failure presenting to the emergency department: a retrospective cohort study

  2025cites this paper
• ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing.

  2025cites this paper
• The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy: How to Guide Clinical Decision-Making?

  2024cites this paper
• Cardiomyopathy and Sudden Cardiac Death: Bridging Clinical Practice with Cutting-Edge Research

  2024cites this paper
• Re-analyses of 8 Historical Trials in Cardiovascular Medicine Assessing Multimorbidity Burden and its Association with Treatment Response.

  2024cites this paper
• Computational Medicine: What Electrophysiologists Should Know to Stay Ahead of the Curve

  2024cites this paper
• Rationale and Design of a Multicenter Trial on Exploratory Analysis of the Effects of Advance Care Planning Guided by the Prediction Program of Heart Failure Prognosis on Quality of Life in Patients With Heart Failure　― ACQUAINT-Trial ―

  2024cites this paper
• Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular Disorders.

  2024cites this paper
• Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide

  2023cites this paper
• The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy: How to Guide Clinical Decision-Making?

  2023cites this paper
• Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies

  2023cites this paper
• Potential of β2AR for added benefit in treating heart failure through a better understanding of signaling

  2023cites this paper
• The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database.

  2023cites this paper
• The value of NT-pro-brain natriuretic peptide and left ventricular ejection fraction for prediction of premature ventricular complexes burden.

  2023cites this paper
• Machine Learning-Based Phenomapping in Patients with Heart Failure and Secondary Prevention Implantable Cardioverter-Defibrillator Implantation: A Proof-of-Concept Study

  2023cites this paper
• Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights from REALITY-AHF

  2023cites this paper
• Hematologic Parameters as Predictors of Long-Term Mortality in Infective Endocarditis Patients

  2023cites this paper
• Changes in cellular Ca2+ and Na+ regulation during the progression towards heart failure

  2022cites this paper
• Disturbances in Brain-Heart Neuronal-Metabolic Axis Are Associated With Major Arrhythmic Events in Heart Failure.

  2022cites this paper
• Neurometabolism and Ventricular Dyssynchrony in Patients With Heart Failure and Reduced Ejection Fraction.

  2022cites this paper
• [Cardiac contractility modulation in heart failure with reduced ejection fraction treatment].

  2022cites this paper
• Amino acid profiling to predict prognosis in patients with heart failure: an expert review

  2022cites this paper
• Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE

  2021cites this paper
• Left ventricular hypertrophy and sudden cardiac death

  2021cites this paper
• Sudden cardiac death after acute decompensation in heart failure patients: implications of discharge haemoglobin levels

  2021cites this paper
• Prognostic significance of the HFA‐PEFF score in patients with heart failure with preserved ejection fraction

  2021cites this paper
• Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper.

  2021cites this paper
• Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper.

  2021cites this paper
• Usefulness of the MAGGIC Score in Predicting the Competing Risk of Non-Sudden Death in Heart Failure Patients Receiving an Implantable Cardioverter-Defibrillator: A Sub-Analysis of the OBSERVO-ICD Registry

  2021cites this paper
• Does high sensitivity troponin add prognostic value to validated risk scores to predict in-hospital mortality in patients with acute heart failure?

  2021cites this paper
• Sudden Cardiac Death Prediction in Non-ischemic Dilated Cardiomyopathy: a Multiparametric and Dynamic Approach

  2020cites this paper
• Decompensation in Critical Care: Early Prediction of Acute Heart Failure Onset

  2020cites this paper
• Deep Learning for Cardiovascular Risk Stratification

  2020cites this paper
• Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model

  2020cites this paper
• Incidence of Dysphagia and Its Association With Functional Recovery and 1-Year Mortality in Hospitalized Older Patients With Heart Failure: A Prospective Cohort Study.

  2020cites this paper
• Mildly symptomatic heart failure with reduced ejection fraction: diagnostic and therapeutic considerations

  2020cites this paper
• CRISPLD1: a novel conserved target in the transition to human heart failure

  2020cites this paper
• Circular RNA in Diseased Heart

  2020cites this paper
• [Model of Two-Years Forecasting of the Anti-Existent Patients With Acute Decompensation of Heart Failure on the Background of the Intermediate Fraction of Left Ventricle].

  2020cites this paper
• ACEi to ARNi: “The Switch” An Evidence Based Review

  2020cites this paper
• Sequential organ failure assessment score on admission predicts long‐term mortality in acute heart failure patients

  2020cites this paper
• Sudden death in the prehospital setting in times of COVID-19

  2020cites this paper
• Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction

  2020cites this paper
• Sex-specific risk assessment of sudden cardiac death

  2020cites this paper
• Sudden death in the out-of-hospital setting in times of covid-19/ Muerte súbita en el ámbito prehospitalario en época de covid-19

  2020cites this paper
• Separating the Forest From the Trees: New Tools for a Personalized Sudden Cardiac Death Risk Stratification

  2020cites this paper
• Differential prognostic accuracy of right ventricular dysfunction, the Seattle heart failure model and the MAGGIC score in patients with severe mitral regurgitation undergoing the MitraClip® procedure

  2020cites this paper
• Randomized trial of a left ventricular assist device as destination therapy versus guideline‐directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial

  2020cites this paper
• The evolving risk of sudden cardiac death after heart transplant. An analysis of the ISHLT Thoracic Transplant Registry

  2019cites this paper
• The Role of GDF-15 in Heart Failure Patients With Chronic Kidney Disease.

  2019cites this paper
• CMR DENSE and the Seattle Heart Failure Model Inform Survival and Arrhythmia Risk After CRT.

  2019cites this paper
• Persistent Heart Failure Symptoms at Hospital Discharge Predicts 30-Day Clinical Events

  2019cites this paper
• Safety of Outpatient Milrinone Infusion in End Stage Heart Failure: ICD-Level Data on Atrial Fibrillation and Ventricular Tachyarrhythmias.

  2019cites this paper
• IAJPS 2019 , 06 ( 01 ) , 1565-1570

  2019cites this paper
• 14 Unresolved Issues and Future Perspectives

  2019cites this paper
• Cardiovascular and non‐cardiovascular death distinction: the utility of troponin beyond N‐terminal pro‐B‐type natriuretic peptide. Findings from the BIOSTAT‐CHF study

  2019cites this paper
• Digital Medicine and Evolution of Remote Patient Monitoring in Cardiac Electrophysiology: A State-of-the-Art Perspective

  2019cites this paper
• A bio-clinical approach for prediction of sudden cardiac death in outpatients with heart failure: The ST2-SCD score.

  2019cites this paper
• Unresolved Issues and Future Perspectives

  2019cites this paper
• The prognostic role of different renal function phenotypes in patients with acute heart failure.

  2019cites this paper
• Modes of death and prognostic outliers in chronic heart failure

  2019cites this paper
• The left atrium and the right ventricle: two supporting chambers to the failing left ventricle

  2019cites this paper
• MiRNA-182 regulates the cardiomyocyte apoptosis in heart failure.

  2019cites this paper
• Critères pronostiques de mortalité dans l'insuffisance cardiaque dans une cohorte prospective du CHU Grenoble-Alpes

  2018cites this paper
• Évaluation des facteurs pronostiques en fonction de la prise en charge délivrée chez les patients porteurs d’une insuffisance cardiaque à fraction d’éjection réduite

  2018cites this paper
• Should we rethink the indications for implantable cardioverter‐defibrillators in non‐ischaemic dilated cardiomyopathy?

  2018cites this paper
• Validation of 2-year 123I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure

  2018cites this paper
• Descent into heart and lung failure

  2018cites this paper
• The role of sacubitril/valsartan therapy on renal function and glucose metabolism in chronic heart failure patients

  2018cites this paper
• It’s Time to Talk: Challenges in Providing Integrated Palliative Care in Advanced Congestive Heart Failure. A Narrative Review

  2018cites this paper
• Incidence and predictors of sudden cardiac death after heart transplantation: A systematic review and meta‐analysis

  2018cites this paper
• Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular risk.

  2018cites this paper
• Utility of Left Atrial Expansion Index and Stroke Volume in Management of Chronic Systolic Heart Failure

  2018cites this paper
• Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects

  2018cites this paper
• Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry.

  2018cites this paper
• The Elusiveness of Titanium Immortality.

  2018cites this paper
• Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates.

  2018cites this paper
• Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.

  2018cites this paper
• Primary prevention implantable cardioverter-defibrillator and opportunities for sudden cardiac death risk assessment in non-ischaemic cardiomyopathy

  2018cites this paper
• Sudden death risk markers for patients with left ventricular ejection fractions greater than 40.

  2018cites this paper
• Effect of albumin-globulin score and albumin to globulin ratio on survival in patients with heart failure: a retrospective cohort study in China

  2018cites this paper
• A Tale of Two Failures: A Guide to Shared Decision-Making for Heart and Renal Failure.

  2018cites this paper
• Sarcoplasmic reticulum calcium leak contributes to arrhythmia but not to heart failure progression

  2018cites this paper
• Editorial commentary: Sudden cardiac death prediction in the general population and among patients with left ventricular ejection fractions greater than 40.

  2018cites this paper
• New Prognostic Risk Calculator for Heart Failure.

  2018cites this paper
• Gr upSM The Mechanical Assistance Devices in Advanced Heart Failure Treatment as Bridge to Life

  2017cites this paper
• Selecting Patients With Nonischemic Dilated Cardiomyopathy for ICDs: Myocardial Function, Fibrosis, and What's Attached?

  2017cites this paper
• Declining Risk of Sudden Death in Heart Failure.

  2017cites this paper
• The role of spatial organization of Ca2+ release sites in the generation of arrhythmogenic diastolic Ca2+ release in myocytes from failing hearts

  2017cites this paper
• Declining Risk of Sudden Death in Heart Failure.

  2017cites this paper
• Особенности лечения нарушений ритма сердца при беременности

  2017cites this paper
• Who Benefits From Implantable Cardioverter-Defibrillators?: Integrating Absolute, Proportional, and Competing Risk.

  2017cites this paper
• Declining Risk of Sudden Death in Heart Failure.

  2017cites this paper